Evidence grows that melanoma drugs benefit some lung cancer patients

A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to treat melanoma, the authors of a new academic clinical trial in Europe have reported at the European Lung Cancer Conference in Geneva, Switzerland. —> Read More